- Details
Pfizer today announced it reached a $160 billion deal to merge with Allergan.
- Details
Eyegate Pharmaceuticals announced promising interim data showing iontophoresis can non-invasively deliver dexamethasone phosphate to the posterior segment.
- Details
The authors of this randomized trialfound that neither cataract surgery nor IOL type have a significant impact on circadian photoentrainment or sleep quality.
- Details
Allergan announced it will develop and commercialize dry eye drug tavilermide through an exclusive licensing agreement with Mimetogen Pharmaceuticals.
- Details
Researchers have identified a steroid that has the potential to reverse cataracts by blocking α-crystallin aggregation.
- Details
Study finds that glaucoma patients are at higher risk for complications and show weaker visual improvement.
Read more: Cataract surgery in glaucoma patients: More risks, less benefit